Plasmapheresis in Acute Hypertriglyceridemia‐Induced Pancreatitis—The PHIP‐JuGa‐Study
United European Gastroenterology Journal · 2025
DOI: 10.1002/ueg2.70097 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift United European Gastroenterology Journal, 2025. Verfasst von Jonas J Staudacher und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Rheumatology and Infectiology, Charité-University Medicine Berlin-Campus Benjamin Franklin, Berlin, Germany. Hauptthemen laut MEDLINE: Plasmapheresis, Hypertriglyceridemia, Pancreatitis. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background and Aims The incidence of acute pancreatitis is increasing in the Western world. About 10% of cases are caused by hypertriglyceridemia. Plasmapheresis was shown to reduce serum triglyceride (TG) levels, and current apheresis guidelines recommend its use in severe acute hypertriglyceridemia‐induced pancreatitis (HIP). However, data on safety and efficacy are lacking. This study aimed to evaluate the clinical efficacy of plasmapheresis in hypertriglyceridemia‐induced pancreatitis.
Methods
This is a retrospective multicenter cohort study of patients hospitalized for an episode of hypertriglyceridemia‐induced pancreatitis from January 1, 2012 to December 31, 2022. The predefined composite primary endpoint was in‐hospital mortality and organ failure. To reduce allocation bias, we performed propensity score matching.
Results
245 episodes of hypertriglyceridemia‐induced pancreatitis from 13 German centers were included. Of those, 95 episodes were treated with plasmapheresis. After propensity score matching, the final cohort consisted of 60 well‐balanced pairs. Plasmapheresis was not associated with a difference in the primary composite outcome, in‐hospital mortality, and organ failure (8/60 vs. 5/60; χ 2 (1) = 0.776; p = 0.378), nor was there any difference in the severity of pancreatitis episodes. It showed only a moderate reduction of serum triglyceride compared to the non‐plasmapheresis group, but a significantly longer hospital stay in the plasmapheresis group (12 days; IQR 14 vs. 9 days; IQR 11; U = 1356; Z = −2.46; p = 0.014).
Conclusions
Plasmapheresis in patients with hypertriglyceridemia‐induced pancreatitis was not associated with a better clinical outcome compared with conservative treatment in this propensity score‐matched retrospective cohort study. Outside clinical studies, this costly and potentially complicative treatment should be considered with caution.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Rheumatology and Infectiology, Charité-University Medicine Berlin-Campus Benjamin Franklin, Berlin, Germany.
- Berlin Institute of Health at Charité, Berlin, Germany.
- Department of Hepatology and Gastroenterolgy CCM/CVK, Charité-Universitätsmedizin Berlin, Berlin, Deutschland.
- Department of Medicine II, Medical Faculty at Mannheim, University of Heidelberg, Mannheim, Germany.
- Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, and Infectious Diseases, University Hospital Regensburg, Regensburg, Germany.
- Medical Clinic III, Gastroenterology, Metabolic Diseases and Intensive Care, University Hospital RWTH Aachen, Aachen, Germany.
ORCID-Profile: Jonas J Staudacher, Elisabeth Blüthner, Karim Hamesch, Christoph Ammer-Herrmenau, Jakob Garbe, Rene Wilke, Marlies Vornhülz, Georg Beyer, Dominik Bettinger
Zitieren
APA
Staudacher, J. J., Blüthner, E., Murillo, K., Boldt, M., Hamesch, K., Kruse, L., Sulzer, S., Ammer-Herrmenau, C., Huber, Y., Weinmann-Menke, J., Kramer, C., Garbe, J., Wilke, R., Mücke, M. M., Heilani, M. W., Orgler-Gasche, E., Vornhülz, M., Beyer, G., Wiesehahn, L., …, & JuGa study group (2025). Plasmapheresis in Acute Hypertriglyceridemia‐Induced Pancreatitis—The PHIP‐JuGa‐Study. United European Gastroenterology Journal. https://doi.org/10.1002/ueg2.70097
Vancouver
Staudacher JJ, Blüthner E, Murillo K, Boldt M, Hamesch K, Kruse L, et al. Plasmapheresis in Acute Hypertriglyceridemia‐Induced Pancreatitis—The PHIP‐JuGa‐Study. United European Gastroenterology Journal. 2025. doi:10.1002/ueg2.70097
BibTeX
@article{Staudacher2025,
author = {Staudacher, Jonas J and Blüthner, Elisabeth and Murillo, Katharina and Boldt, Manja and Hamesch, Karim and Kruse, Leah and Sulzer, Sabrina and Ammer-Herrmenau, Christoph and Huber, Yvonne and Weinmann-Menke, Julia and Kramer, Charlotte and Garbe, Jakob and Wilke, Rene and Mücke, Marcus M and Heilani, Myriam W and Orgler-Gasche, Elisabeth and Vornhülz, Marlies and Beyer, Georg and Wiesehahn, Lara and Schwanstecher, Annekatrin and Hollenbach, Marcus and Luxenburger, Hendrik and Bettinger, Dominik and Schlosser-Hupf, Sophie and JuGa study group, JuGa study group},
title = {Plasmapheresis in Acute Hypertriglyceridemia‐Induced Pancreatitis—The PHIP‐JuGa‐Study},
journal = {United European Gastroenterology Journal},
year = {2025},
doi = {10.1002/ueg2.70097}
}
EUVIMED